Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

High cortisol levels are associated with cognitive impairment no-dementia (CIND) and dementia.

Lara VP, Caramelli P, Teixeira AL, Barbosa MT, Carmona KC, Carvalho MG, Fernandes AP, Gomes KB.

Clin Chim Acta. 2013 Aug 23;423:18-22. doi: 10.1016/j.cca.2013.04.013. Epub 2013 Apr 20.

2.

Cortisol, HDL-c, VLDL-c, and APOE Polymorphisms as Laboratorial Parameters Associated to Cognitive Impairment No Dementia (CIND) and Dementia.

Lara VP, Caramelli P, Teixeira AL, Barbosa MT, Carmona KC, Guimarães HC, Carvalho MG, Fernandes AP, Gomes KB.

J Clin Lab Anal. 2016 Sep;30(5):374-80. doi: 10.1002/jcla.21865. Epub 2015 Aug 24.

PMID:
26302887
4.

APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.

Ballard CG, Morris CM, Rao H, O'Brien JT, Barber R, Stephens S, Rowan E, Gibson A, Kalaria RN, Kenny RA.

Neurology. 2004 Oct 26;63(8):1399-402.

PMID:
15505155
5.

The relationship between cognitive impairment plasma cortisol levels and HPA responsibility to dexamethasone in dementia.

Gurevitch D, Siegel B, Dumlao MS, Perl E, Chaitin P, Bagne CA, Oxenkrug GF.

Prog Clin Biol Res. 1989;317:175-87.

PMID:
2690099
6.

Apolipoprotein E gene, environmental risk factors, and their interactions in dementia among seniors.

Meng X, D'Arcy C.

Int J Geriatr Psychiatry. 2013 Oct;28(10):1005-14. doi: 10.1002/gps.3918. Epub 2012 Dec 17.

PMID:
23255503
7.

Increased CSF cortisol in AD is a function of APOE genotype.

Peskind ER, Wilkinson CW, Petrie EC, Schellenberg GD, Raskind MA.

Neurology. 2001 Apr 24;56(8):1094-8.

PMID:
11320185
8.

Genetic determinants of "cognitive impairment, no dementia".

Dubé JB, Johansen CT, Robinson JF, Lindsay J, Hachinski V, Hegele RA.

J Alzheimers Dis. 2013;33(3):831-40. doi: 10.3233/JAD-2012-121477.

PMID:
23042215
9.

A prospective study of diurnal cortisol and cognitive function in community-dwelling elderly people.

Beluche I, Carrière I, Ritchie K, Ancelin ML.

Psychol Med. 2010 Jun;40(6):1039-49. doi: 10.1017/S0033291709991103. Epub 2009 Oct 9.

10.

Plasma levels of apolipoprotein E and cognitive function in old age.

Mooijaart SP, van Vliet P, van Heemst D, Rensen PC, Berbée JF, Jolles J, de Craen AJ, Westendorp RG.

Ann N Y Acad Sci. 2007 Apr;1100:148-61.

PMID:
17460173
11.

[Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].

Rosich-Estragó M, Figuera-Terré L, Mulet-Pérez B, Arrufat-Cardús MT, Pascual San Emeterio A, Arbeola-Rigau I, Labad-Alquézar A, Vilella-Cuadrada E.

Rev Neurol. 2004 May 1-15;38(9):801-7. Spanish.

12.

Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging.

Ebly EM, Hogan DB, Parhad IM.

Arch Neurol. 1995 Jun;52(6):612-9.

PMID:
7763211
13.

Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.

Yip AG, Brayne C, Easton D, Rubinsztein DC; Medical Research Council Cognitive Function Ageing Study (MRC CFAS)..

J Med Genet. 2002 Sep;39(9):639-43.

14.

Associations of serum cortisol with cognitive function and dementia: the Rotterdam Study.

Schrijvers EM, Direk N, Koudstaal PJ, Kirschbaum C, Hofman A, Tiemeier H, Breteler MM.

J Alzheimers Dis. 2011;25(4):671-7. doi: 10.3233/JAD-2011-110224.

PMID:
21483093
15.

Dementia, quantitative neuroimaging, and apolipoprotein E genotype.

Bigler ED, Lowry CM, Anderson CV, Johnson SC, Terry J, Steed M.

AJNR Am J Neuroradiol. 2000 Nov-Dec;21(10):1857-68.

16.

Cognitive impairment and cortisol resistance to dexamethasone suppression in elderly depression.

Siegel B, Gurevich D, Oxenkrug GF.

Biol Psychiatry. 1989 Jan 15;25(2):229-34.

PMID:
2930804
17.

Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.

Orsitto G, Seripa D, Panza F, Franceschi M, Cascavilla L, Placentino G, Matera MG, Paris F, Capurso C, Solfrizzi V, Dallapiccola B, Pilotto A.

Dement Geriatr Cogn Disord. 2007;23(5):327-33. Epub 2007 Mar 19.

PMID:
17374951
18.

APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.

Kurz MW, Dekomien G, Nilsen OB, Larsen JP, Aarsland D, Alves G.

J Geriatr Psychiatry Neurol. 2009 Sep;22(3):166-70. doi: 10.1177/0891988709332945. Epub 2009 Mar 25.

PMID:
19321880
19.

Acute and long-term associations between ApoE genetic polymorphism, cortisol levels, and declarative memory performance in older adults.

Fiocco AJ, Poirier J, Joober R, Nair NP, Lupien SJ.

Psychoneuroendocrinology. 2008 Jun;33(5):625-33. doi: 10.1016/j.psyneuen.2008.02.002. Epub 2008 Apr 18.

PMID:
18374494
20.

APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old.

Juva K, Verkkoniemi A, Viramo P, Polvikoski T, Kainulainen K, Kontula K, Sulkava R.

Neurology. 2000 Jan 25;54(2):412-5.

PMID:
10668704

Supplemental Content

Support Center